Counsyl
Counsyl
Claim
Counsyl offers non-invasive reproductive health tests. Counsyl was acquired in 2018 by Myriad Genetics, a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases. Counsyl’s genetic tests such as the Foresight test and Prelude test enabled Myriad Genetics to expand into the carrier screening and non-invasive prenatal screening markets.Counsyl offers non-invasive reproductive health tests. Counsyl was acquired in 2018 by Myriad Geneti Show More
Alpha Score
$ 612.80 M
Alpha Score
49.2
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0